Mark Ward
Mark Ward is Operations Director at Star. To find out more about Star’s innovative outsourcing and resourcing solutions, please email outsourcing@starmedical.co.uk or resourcing@starmedical.co.uk. If you’re on the hunt for a new role, or just curious what’s out there, email your CV to candidates@starmedical.co.uk, or call 01225 336 335 to speak to a member of our team.
Latest articles
Fewer than half of US clinical trials comply with law on reporting results
Research into reporting of US clinical trial results finds that less than half (41%) are reported promptly onto the US trial registry, and one...
Study confirms benefits of blood anticoagulants for heart failure patients
British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
Lynparza regulatory submission granted Priority Review in US
AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...
Popular articles
Mapping the intricate oncology landscape
Simon Grime, of Wilmington Healthcare, explains how data and intelligence tools help pharma deliver tailored engagement programmes to diverse stakeholders in an intricate oncology...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Lynparza regulatory submission granted Priority Review in US
AstraZeneca and MSD have announced that a supplemental New Drug Application for Lynparza (olaparib) has been accepted and granted Priority Review in the US...
Study confirms benefits of blood anticoagulants for heart failure patients
British clinical AI technology company Sensyne Health has announced its part in the results of a study seeking to identify if there are benefits...
Fewer than half of US clinical trials comply with law on reporting results
Research into reporting of US clinical trial results finds that less than half (41%) are reported promptly onto the US trial registry, and one...